Skip to main content
Fig. 3 | Journal of Nanobiotechnology

Fig. 3

From: All-in-one approaches for triple-negative breast cancer therapy: metal-phenolic nanoplatform for MR imaging-guided combinational therapy

Fig. 3

A The viability of 4T1 cells after different treatments (n = 6). B 4T1 cells stained by Calcein-AM/PI kit after different treatments. Scale bars were 20 μm. C The cellular uptake of coumarin-6 labeled BFE NPs and BFE@BSA NPs. Scale bars were 20 μm. D Schematic illustration of intracellular mechanisms. E The flow cytometry analysis of ROS generation after different treatments and (F) corresponding MFI values (n = 3). G The fluorescence images of ROS probes after different treatments. Scale bars were 50 μm. Statistical p values verse the control group: *p < 0.05, **p < 0.01, ***p < 0.001

Back to article page